Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianda Pharmaceuticals has established itself as a leading developer of both traditional Chinese medicine and modern pharmaceuticals. Its core commercial products include Tuoping valsartan capsules for cardiovascular disease (#1 in China by sales volume) and Tuoen ibuprofen suspension for pediatrics (#3 market share in China). The company operates an integrated industrial chain from raw materials to clinics ("TDMall"), with ongoing R&D into innovative chemical drugs and new TCM formulations. Several new drug candidates are at the registration stage or expected to launch within the next two years. The company also provides CDMO/CMO services with more than 20 projects signed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianda Pharmaceuticals.